Ischemia-Modified Albumin (IMA) is a marker of myocardial ischemia rather than myocardial injury. Early clinical manifestations of myocardial ischemia are often vague and diverse, may include chest pain, upper abdominal and arm discomfort, panting, malignant and vomiting, so it is not easy to identify. Studies have found that IMA increase in 5 ~ 10 min after ischemia occurred and last about 3~6 h before recovered to normal level. This is crucial for the early detection of acute myocardial ischemia and recurrent myocardial ischemia within 24h. Myocardial ischemia is the most common cause of acute coronary syndrome, IMA determination can used for accurate risk stratification and prognosis judgement of acute coronary syndrome.
Açıklama
Ischemia-Modified Albumin (IMA) is a marker of myocardial ischemia rather than myocardial injury. Early clinical manifestations of myocardial ischemia are often vague and diverse, may include chest pain, upper abdominal and arm discomfort, panting, malignant and vomiting, so it is not easy to identify. Studies have found that IMA increase in 5 ~ 10 min after ischemia occurred and last about 3~6 h before recovered to normal level. This is crucial for the early detection of acute myocardial ischemia and recurrent myocardial ischemia within 24h. Myocardial ischemia is the most common cause of acute coronary syndrome, IMA determination can used for accurate risk stratification and prognosis judgement of acute coronary syndrome.
İçerik
| Reagent 1 | 1 x 30 ml |
| Reagent 2 | 1 x 8 ml |
